These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32892710)

  • 1. Sample size determination for Bayesian analysis of small n sequential, multiple assignment, randomized trials (snSMARTs) with three agents.
    Wei B; Braun TM; Tamura RN; Kidwell K
    J Biopharm Stat; 2020 Nov; 30(6):1109-1120. PubMed ID: 32892710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Bayesian analysis of small n sequential multiple assignment randomized trials (snSMARTs).
    Wei B; Braun TM; Tamura RN; Kidwell KM
    Stat Med; 2018 Nov; 37(26):3723-3732. PubMed ID: 30010207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic treatment regimens in small n, sequential, multiple assignment, randomized trials: An application in focal segmental glomerulosclerosis.
    Chao YC; Trachtman H; Gipson DS; Spino C; Braun TM; Kidwell KM
    Contemp Clin Trials; 2020 May; 92():105989. PubMed ID: 32200006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A small n sequential multiple assignment randomized trial design for use in rare disease research.
    Tamura RN; Krischer JP; Pagnoux C; Micheletti R; Grayson PC; Chen YF; Merkel PA
    Contemp Clin Trials; 2016 Jan; 46():48-51. PubMed ID: 26586608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and analysis considerations for utilizing a mapping function in a small sample, sequential, multiple assignment, randomized trials with continuous outcomes.
    Hartman H; Tamura RN; Schipper MJ; Kidwell KM
    Stat Med; 2021 Jan; 40(2):312-326. PubMed ID: 33111381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Power prior models for estimating response rates in a small n, sequential, multiple assignment, randomized trial.
    Chao YC; Braun TM; Tamura RN; Kidwell KM
    Stat Methods Med Res; 2022 Dec; 31(12):2297-2309. PubMed ID: 36082955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian methods to compare dose levels with placebo in a small n, sequential, multiple assignment, randomized trial.
    Fang F; Hochstedler KA; Tamura RN; Braun TM; Kidwell KM
    Stat Med; 2021 Feb; 40(4):963-977. PubMed ID: 33216360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving efficiency in the stepped-wedge trial design via Bayesian modeling with an informative prior for the time effects.
    Zhan D; Ouyang Y; Xu L; Wong H
    Clin Trials; 2021 Jun; 18(3):295-302. PubMed ID: 33813906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addressing sequential and concurrent treatment regimens in a small n sequential, multiple assignment, randomized trial (snSMART) in the MISTIC study.
    Cheng Y; Tremoulet A; Burns J; Jain S
    J Biopharm Stat; 2023 Dec; ():1-19. PubMed ID: 38095587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal sample size determination for single-arm trials in pediatric and rare populations with Bayesian borrowing.
    Ji Z; Lin J; Lin J
    J Biopharm Stat; 2022 Jul; 32(4):529-546. PubMed ID: 35604836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic enrichment of Bayesian small-sample, sequential, multiple assignment randomized trial design using natural history data: a case study from Duchenne muscular dystrophy.
    Wang S; Kidwell KM; Roychoudhury S
    Biometrics; 2023 Dec; 79(4):3612-3623. PubMed ID: 37323055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Bayesian sequential design with adaptive randomization for 2-sided hypothesis test.
    Yu Q; Zhu L; Zhu H
    Pharm Stat; 2017 Nov; 16(6):451-465. PubMed ID: 28980435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
    Lewis RJ; Lipsky AM; Berry DA
    Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Bayesian multi-arm multi-stage clinical trial design incorporating information about treatment ordering.
    Serra A; Mozgunov P; Jaki T
    Stat Med; 2023 Jul; 42(16):2841-2854. PubMed ID: 37158302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BASIC: A Bayesian adaptive synthetic-control design for phase II clinical trials.
    Jiang L; Thall PF; Yan F; Kopetz S; Yuan Y
    Clin Trials; 2023 Oct; 20(5):486-496. PubMed ID: 37313712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian methods for the design and interpretation of clinical trials in very rare diseases.
    Hampson LV; Whitehead J; Eleftheriou D; Brogan P
    Stat Med; 2014 Oct; 33(24):4186-201. PubMed ID: 24957522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sample size considerations for comparing dynamic treatment regimens in a sequential multiple-assignment randomized trial with a continuous longitudinal outcome.
    Seewald NJ; Kidwell KM; Nahum-Shani I; Wu T; McKay JR; Almirall D
    Stat Methods Med Res; 2020 Jul; 29(7):1891-1912. PubMed ID: 31571526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Bayesian sequential design using alpha spending function to control type I error.
    Zhu H; Yu Q
    Stat Methods Med Res; 2017 Oct; 26(5):2184-2196. PubMed ID: 26187736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Bayesian-frequentist two-stage single-arm phase II clinical trial design.
    Dong G; Shih WJ; Moore D; Quan H; Marcella S
    Stat Med; 2012 Aug; 31(19):2055-67. PubMed ID: 22415966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bayesian single-arm phase II trial designs with time-to-event endpoints.
    Wu J; Pan H; Hsu CW
    Pharm Stat; 2021 Nov; 20(6):1235-1248. PubMed ID: 34085764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.